Reward Learning, Neurocognition, Social Cognition, and Symptomatology in Psychosis by Kathryn E. Lewandowski et al.
June 2016 | Volume 7 | Article 1001
Original research
published: 14 June 2016
doi: 10.3389/fpsyt.2016.00100
Frontiers in Psychiatry | www.frontiersin.org
Edited by: 
Peter Gallagher, 
Newcastle University, UK
Reviewed by: 
Jonathan K. Wynn, 
University of California Los Angeles, 
USA  
Michele Fornaro, 
Columbia University, USA
*Correspondence:
Kathryn E. Lewandowski 
klewandowski@mclean.harvard.edu
Specialty section: 
This article was submitted to Affective 
Disorders and Psychosomatic 
Research, 
a section of the journal 
Frontiers in Psychiatry
Received: 05 February 2016
Accepted: 26 May 2016
Published: 14 June 2016
Citation: 
Lewandowski KE, Whitton AE, 
Pizzagalli DA, Norris LA, Ongur D and 
Hall M-H (2016) Reward Learning, 
Neurocognition, Social Cognition, 
and Symptomatology in Psychosis. 
Front. Psychiatry 7:100. 
doi: 10.3389/fpsyt.2016.00100
reward learning, neurocognition, 
social cognition, and 
symptomatology in Psychosis
Kathryn E. Lewandowski1,2*, Alexis E. Whitton2,3, Diego A. Pizzagalli2,3, Lesley A. Norris1, 
Dost Ongur1,2 and Mei-Hua Hall1, 2
1 Schizophrenia and Bipolar Disorder Program, McLean Hospital, Belmont, MA, USA, 2 Department of Psychiatry, 
Harvard Medical School, Boston, MA, USA, 3 Center for Depression, Anxiety, and Stress Research, McLean Hospital, 
Belmont, MA, USA
Background: Patients with psychosis spectrum disorders exhibit deficits in social and 
neurocognition, as well as hallmark abnormalities in motivation and reward processing. 
Aspects of reward processing may overlap behaviorally and neurobiologically with some 
elements of cognitive functioning, and abnormalities in these processes may share 
partially overlapping etiologies in patients. However, whether reward processing and 
cognition are associated across the psychoses and linked to state and trait clinical 
symptomatology is unclear.
Method: The present study examined associations between cognitive functioning, 
reward learning, and clinical symptomatology in a cross-diagnostic sample. Patients 
with schizophrenia (SZ; n =  37), bipolar I disorder with psychosis (BD; n =  42), and 
healthy controls (n = 29) were assessed for clinical symptoms (patients only), neuro-
cognitive functioning using the MATRICS Battery (MCCB) and reward learning using 
the probabilistic reward task (PRT). Groups were compared on neurocognition and PRT 
response bias, and associations between PRT response bias and neurocognition or 
clinical symptoms were examined controlling for demographic variables and PRT task 
difficulty (discriminability).
results: Patients with SZ performed worse than controls on most measures of neu-
rocognition; patients with BD exhibited deficits in some domains between the level of 
patients with SZ and controls. The SZ – but not BD – group exhibited deficits in social 
cognition compared to controls. Patients and controls did not differ on PRT response 
bias, but did differ on PRT discriminability. Better response bias across the sample was 
associated with poorer social cognition, but not neurocognition; conversely, discrim-
inability was associated with neurocognition but not social cognition. Symptoms of 
psychosis, particularly negative symptoms, were associated with poorer response bias 
across patient groups.
Discussion: Reward learning was associated with symptoms of psychosis – in particu-
lar negative symptoms – across diagnoses, and was predictive of worse social cognition. 
Reward learning was not associated with neurocognitive performance, suggesting that, 
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inTrODUcTiOn
Across diagnostic boundaries, patients with psychosis spectrum 
disorders exhibit substantial deficits in social and neurocogni-
tion, as well as hallmark abnormalities in motivation and reward 
processing. These cognitive and reward processing abnormalities 
are associated with poor community outcomes, disability, and 
reduced subjective quality of life (1–3).
Patients with schizophrenia (SZ) exhibit substantial deficits in 
multiple cognitive processes, including attention, memory, and 
executive functioning (4). Although cognitive deficits in patients 
with bipolar disorder (BD) have been found to fall between the 
level of healthy controls and patients with SZ (5), some studies 
have shown that BD patients with a history of psychosis exhibit 
neurocognitive performance similar to patients on the SZ spec-
trum (6, 7). The study of social cognitive dysfunction across the 
psychoses has yielded mixed findings: whereas patients with SZ 
exhibit pronounced deficits in many aspects of social cognition, 
patients with BD are characterized by more selective deficits 
(8–10). For instance, patients with BD show deficits in emotion 
processing and theory of mind (ToM), but not on tasks that assess 
the ability to anticipate social outcomes or emotional responsivity 
to social situations (8, 10). Thus, whereas deficits in the so-called 
“cold” cognition may not differ substantively across psychosis 
spectrum disorders, deficits in social cognition may differ quali-
tatively by diagnosis.
There is evidence that many, but not all, aspects of reward 
processing are abnormal in patients with psychosis. In particular, 
patients with SZ appear to have deficits in anticipatory but not 
consummatory pleasure (11, 12); difficulty with value representa-
tion but not reward learning per se (13); and difficulty with rapid 
reward-based learning but not gradual learning (3). Patients with 
BD also exhibit abnormalities in reward processing across vari-
ous phases of illness (14, 15); specifically, patients in both manic 
and euthymic states exhibit abnormalities in the modulation 
of behavior in response to variable reward, impulsivity-related 
abnormalities in reward processing, and poor integration of 
reinforcements over time (14, 16).
Whether deficits in reward processing differ categorically by 
diagnosis or are more closely linked to state and trait clinical 
symptomatology is unclear. A recent study examining reward 
learning using a probabilistic reward learning paradigm in a 
cross-diagnostic sample of patients with SZ or BD (with or with-
out psychosis) found that patients with SZ were characterized by 
the greatest abnormalities; however, across patient groups, deficits 
in reinforcement learning were associated with state severity of 
psychotic symptoms (17). Similarly, abnormalities in anticipatory 
pleasure were associated with anhedonia (AD) in patients with 
SZ or major mood disorders (11, 16, 18). However, a recent study 
found that patients with SZ exhibited lower hedonic experience 
and behavioral activation than patients with BD despite similar 
levels of negative affect and trait AD (19). Together, these mixed 
findings indicate that additional research is needed to clarify the 
relationships among aspects of reward processing, state clinical 
symptoms, and diagnostic categories.
Recently, examinations of the intersection of reward process-
ing and cognition have highlighted possible interactions between 
aspects of reward processing (e.g., reward anticipation and 
reward-based decision-making) and cognitive performance (e.g., 
attention, concentration, working memory, and cognitive control) 
(20–25). In one of the few studies to directly examine associations 
between cognition and reward processing in patients with SZ or 
BD, steeper discounting of delayed rewards was associated with 
poorer intelligence and working memory across patient groups 
(26). This intersection is further highlighted by research showing 
that cognitive and reward processing systems share overlapping 
neurobiological correlates. For example, dopamine is associated 
both with cognitive processes, such as working memory and 
cognitive flexibility (27, 28), as well as reward processes, includ-
ing incentive motivation and reinforcement learning (16, 29). 
Furthermore, regions such as the anterior cingulate cortex (ACC) 
have been linked to both reward and cognition (30–33).
Collectively, these data suggest that aspects of reward process-
ing may overlap both behaviorally and neurobiologically with at 
least some elements of cognitive functioning in healthy adults, 
and that abnormalities in these processes may share at least 
partially overlapping etiologies in patients. Given that cogni-
tive dysfunction and reward processing deficits are hallmark 
symptom dimensions across the psychosis spectrum, gaining a 
better understanding of how they relate to one another, to other 
key symptom dimensions (e.g., psychosis), and to diagnostic 
categories may help clarify shared etiological pathways and guide 
efforts toward targeted treatment approaches.
To fill gaps in the literature, the aim of this study was to examine 
associations between neurocognitive functioning, reward learn-
ing, and clinical symptomatology in a cross-diagnostic sample of 
patients with psychosis spectrum disorders and healthy controls. 
We hypothesized that (1) both reward learning and neurocogni-
tive functioning would be impaired in patients with SZ or BD 
compared to controls; (2) impairments in reward learning would 
be associated with poorer neurocognitive and social cognitive 
functioning across patients with SZ and BD; and (3) impairments 
in reward learning would be associated with greater psychotic 
symptom severity.
across patient groups, social cognition but not neurocognition may share common path-
ways with this aspect of reinforcement learning. Better understanding of how cognitive 
dysfunction and reward processing deficits relate to one another, to other key symptom 
dimensions (e.g., psychosis), and to diagnostic categories, may help clarify shared etio-
logical pathways and guide efforts toward targeted treatment approaches.
Keywords: reward, response bias, cognition, social cognition, psychosis, schizophrenia, bipolar disorder
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MaTerials anD MeThODs
Participants
Patients with SZ or schizoaffective disorder (n = 37), bipolar I 
disorder with psychosis (n = 42), and healthy controls (n = 29) 
were recruited through the Schizophrenia and Bipolar Disorder 
Program at McLean Hospital and fliers posted at the hospital. 
Diagnosis was determined by trained clinicians using the 
SCID-IV diagnostic interview in conjunction with all available 
ancillary information from medical records, treatment provid-
ers, and family members. Participants were recruited into one of 
several separate but related studies of cognitive remediation in 
patients with SZ or BD with psychosis, or a study of clinical and 
cognitive characterization of patients with psychotic illness. All 
procedures were approved by the McLean Hospital Institutional 
Review Board. All subjects gave written informed consent; all 
procedures were conducted in accordance with the Declaration 
of Helsinki. Exclusion criteria included history of head trauma 
with loss of consciousness, history of seizure, alcohol or substance 
abuse within the last 3 months, and alcohol or substance depend-
ence within the last year. Control participants had no history of 
a psychiatric diagnosis, no first-degree relatives diagnosed with a 
psychiatric illness, and no history of alcohol or substance abuse 
or dependence.
Materials
Neurocognitive functioning was assessed using the MATRICS 
Consensus Cognitive Battery [MCCB; (34)]. The MCCB 
includes 10 tasks across 7 domains, including Processing Speed 
(Brief Assessment of Cognition in Schizophrenia Symbol 
Coding, Animal Fluency, Trails A), Attention (Continuous 
Performance Test), Working Memory (WMS-III Spatial Span, 
Letter-Number Span), Verbal Learning (Hopkins Verbal 
Learning Test  –  Revised), Visual Learning (Brief Visuospatial 
Memory Test – Revised), Problem Solving (Neuropsychological 
Assessment Battery), and Social Cognition (Mayer–Salovey–
Caruso Emotional Intelligence Test). Total administration time 
is 60–90  min. The MCCB yields 10 subscale scores, 7 domain 
scores, and a composite score.
Reward learning was probed using the probabilistic reward 
task [PRT; (35); modified after Tripp and Alsop (36)]. Grounded 
within signal-detection theory, the PRT provides an index of a 
person’s ability to modulate behavior based on reinforcement. In 
this computer-administered task, participants are presented with 
several trials in which schematic cartoon faces with two eyes and 
a nose are presented on the monitor. Next, a horizontal straight 
line (the mouth) is presented quickly (100 ms) and participants 
are required to indicate via key press whether the mouth was long 
(11.5 mm) or short (13 mm). The task consists of three blocks of 
100 trials, and on 40% of correct trials participants receive a mon-
etary reward of 20 cents (“Correct! You won 20 cents”). Long and 
short mouths were presented at equal frequency, however, unbe-
knownst to participants, correct identification of one stimulus 
(“rich stimulus”) was rewarded three times more frequently than 
the other stimulus (“lean stimulus”). Among healthy controls, this 
asymmetrical reinforcement ratio results in a behavioral response 
bias toward the rich stimulus (35), and the strength of this bias 
is reflective of an individual’s sensitivity to reward. As data were 
compiled from separate but related studies, two different versions 
of the PRT were used, one in which long and short mouths were 
1.5 mm different in length (11.5 versus 13 mm) and one in which 
the mouths were 1 mm different in length (9 and 10 mm). Groups 
differed significantly by task version [χ2(2) = 31.08; p < 0.001], as 
all controls received the same version of the task. Patient groups 
did not differ in terms of distribution of task version [χ2(2) = 2.22; 
p = 0.14].
The Positive and Negative Syndrome Scale [PANSS; (37)], the 
Young Mania Rating Scale [YMRS; (38)], and the Montgomery-
Asberg Depression Rating Scale [MADRS; (39)] were used to evalu-
ate current psychotic and mood symptoms; the Mood and Anxiety 
Symptom Questionnaire [MASQ; (40)] was used to evaluate AD, 
anxious arousal (AA), general distress related to anxiety (GDA), 
and general distress related to depression (GDD); hedonic tone 
was measured using the Snaith–Hamilton Pleasure Scale [SHPS; 
(41)]. Community functioning was evaluated using an abbrevi-
ated version of the Multnomah Community Ability Scale [MCAS; 
(42)]. We administered a modified version, focusing on items that 
directly assessed domains of community functioning, including 
independence in daily living, social involvement and interest, and 
instrumental role functioning. This version included 11 items 
scored 1–5 (higher scores indicate better functioning) for a total of 
55 points. The Hollingshead Four Factor Index of Social Status1 was 
used to calculate parental socioeconomic status (SES). Information 
about medication at the time of assessment was obtained from par-
ticipants and chlorpromazine (CPZ) equivalents were calculated 
based on the recommendations of Baldessarini (43).
Procedures
Cognitive and clinical assessments were typically conducted 
in single sessions lasting ~2  h. PRT administration lasted 
approximately 20–30 min, and was either performed at the end 
of the cognitive and clinical assessments or in a separate session. 
Procedures across all studies were standardized and the same 
study staff completed these assessments.
Scores from the MCCB were age normed using the provided 
scoring software. All subscale, domain, and composite scores are 
presented as normed T scores with a mean of 50 and SD of 10.
The PRT data were subject to a quality control check where 
trials with reaction time <150 ms or >2500 ms were excluded, 
and participants with <55% accuracy, more than 10% outlier 
trials, or a rich:lean reward ratio lower than 2.5:1 (as a result of 
poor accuracy/slow reaction time) were excluded from analysis. 
Signal-detection analysis was used to compute response bias (the 
tendency to bias responding to the rich stimulus) as well as dis-
criminability (the ability to distinguish between the two mouth 
sizes), for each block of the PRT using the following formulae:
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1 Hollingshead AB. Four Factor Index of Social Status. (1975). Unpublished 
working paper.
TaBle 2 | cognitive and reward processing scores by diagnosis.
sZ (n = 37) BD (n = 42) hc (n = 29) Test statistic
cognitive
Processing 44.8 (10.1) 48.5 (12.7) 60.0 (9.1) F(2, 104) = 15.71**
Attention 41.4 (11.8) 44.8 (10.5) 52.7 (8.9) F(2, 104) = 9.51**
WM 43.6 (11.6) 49.1 (9.7) 53.8 (8.3) F(2, 104) = 8.44**
Verbal 44.4 (11.3) 49.5 (9.3) 52.6 (11.0) F(2, 104) = 5.14*
Visual 40.1 (10.8) 45.6 (11.0) 51.1 (6.9) F(2, 104) = 9.68**
Prob Solv 47.7 (10.1) 48.2 (9.5) 50.4 (9.6) F(2, 104) = 0.67 
Social 44.7 (9.5) 51.2 (9.0) 54.4 (10.7) F(2, 104) = 8.83**
Composite 39.8 (11.5) 46.9 (10.7) 55.5 (7.6) F(2, 104) = 18.92**
PrT
RB Block 1 0.11 (0.21) 0.07 (0.17) 0.15 (0.28) F(2, 96) = 1.19
RB Block 2 0.14 (0.23) 0.10 (0.15) 0.16 (0.24) F(2, 97) = 0.92
RB Block 3 0.17 (0.25) 0.14 (0.20) 0.16 (0.30) F(2, 97) = 0.16
RB Main 0.15 (0.20) 0.11 (0.15) 0.16 (0.23) F(2, 96) = 0.63
RB Total 0.13 (0.19) 0.10 (0.13) 0.16 (0.21) F(2, 96) = 0.90 
Discrim. 0.67 (0.39) 0.57 (0.25) 0.92 (0.34) F(2, 96) = 9.95**
*p < 0.01.
**p < 0.001.
TaBle 1 | Demographic and clinical variables by diagnosis.
sZ (n = 37) BD (n = 42) hc (n = 29) Test statistic
Demographic
Age 35.0 (11.9) 29.6 (8.4) 31.0 (10.0) F(2, 105) = 2.88 
Education 14.1 (2.3) 15.6 (1.7) 16.1 (2.1) F(2, 104) = 8.85***
Gender  
(% female)
30% 55% 59% Chi2 = 7.01*
Ethnicity  
(% Caucasian)
89% 98% 100% Chi2 = 5.09
Parental SESa 55.4 (11.9) 52.0 (11.5) 48.6 (10.3) F(2, 47) = 0.94
clinical
CPZ 370.5 (333.0) 173.0 (213.6) N/A t(55) = 2.73**
# hosp. 8.3 (6.4) 5.3 (8.1) N/A t(27) = 1.04 
YMRS 7.0 (6.4) 5.6 (4.9) N/A t(57) = 0.95 
MADRS 8.9 (8.2) 10.3 (8.3) N/A t(59) = -0.66 
PANSS P 13.9 (5.8) 10.5 (4.0) N/A t(57) = 2.68**
PANSS N 12.5 (4.9) 10.3 (3.0) N/A t(57) = 2.14*
PANSS G 27.2 (7.4) 24.2 (6.5) N/A t(57) = 1.67
PANSS Total 54.2 (14.9) 44.7 (10.7) N/A t(57) = 2.88**
MCAS 47.0 (4.5) 49.0 (3.8) N/A t(27) = -1.82
SHPS 1.76 (2.56) 1.87 (2.62) 0.14 (0.44) F(2, 73) = 6.06**
MASQ AA 24.6 (8.3) 23.5 (7.6) 19.6 (5.3) F(2, 72) = 3.56*
MASQ AD 59.5 (21.2) 57.7 (18.6) 44.4 (9.2) F(2, 72) = 6.52**
MASQ GDA 18.8 (8.4) 17.6 (5.5) 14.1 (4.0) F(2, 72) = 4.30*
MASQ GDD 22.0 (11.0) 23.6 (8.4) 15.0 (4.5) F(2, 72) = 9.18***
aParental SES was available for a subset of participants (SZ: n = 16; BD: n = 7; HC: 
n = 27). When patient groups were combined (n = 23) and compared to controls 
(n = 27) the results remained unchanged (t = −0.41, p > 0.05).
*p < 0.05.
**p < 0.01.
***p < 0.001.
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To compute response bias and discriminability for cases that 
had a 0 in the formula, 0.5 was added to each cell of the matrix (44).
statistical approach
Groups were compared on neurocognitive and PRT performance 
using ANOVA and pairwise t-tests with Bonferroni correction. 
Partial correlations examining the association of neurocognitive, 
social cognitive, and reward learning outcomes with clinical 
measures controlling for age and gender were conducted across 
the patient groups and by diagnosis. Associations between PRT 
and MCCB were examined using correlation, and then linear 
regression controlling for demographic variables and PRT task 
difficulty. The association of reward learning and symptom sever-
ity was examined in regression models using PRT as a predictor of 
mania, depression, positive and negative symptoms, and anxiety 
after accounting for the effects of demographic confounders and 
PRT discriminability.
resUlTs
Groups differed on several demographic variables, including 
education (SZ < BD, HC) and gender; groups did not differ on 
level of parental SES (see Table 1). Patient groups differed on sev-
eral measures of state clinical severity, including PANSS Positive, 
Negative, and Total scores, with patients with SZ exhibiting 
higher PANSS scores than BD patients; patients did not differ in 
terms of state mania or depression (see Table 1). Note that overall 
symptom severity in both groups was relatively low. Patients dif-
fered from controls on the SHPS as well as MASQ AA, AD, GDA, 
and GDD scores, but did not differ from each other. Patients did 
not differ from each other on the MCAS community functioning 
measure.
cognitive Functioning
ANOVA results showed that groups differed significantly on 
the MCCB Social Cognition domain and on all neurocognitive 
domains except Problem Solving (see Table 2; Figure 1). Pairwise 
comparisons of the significant findings (i.e., all domains except 
Problem Solving) with Bonferroni correction revealed that 
patients with SZ performed worse than HC on all neurocogni-
tive and social cognitive domains, and the Cognitive Composite 
(p <  0.05 to p <  0.001; Cohen’s d =  0.74–1.61). Patients with 
BD performed worse than HC on Processing Speed [t(69) = 4.19; 
p <  0.001; Cohen’s d =  1.04], Attention [t(69) =  3.32; p <  0.01; 
Cohen’s d =  0.81], and the Composite [t(69) =  3.75; p <  0.01; 
Cohen’s d = 0.93]. Patients with BD and SZ differed on Working 
Memory [SZ <  BD; t(76) = −2.31 p <  0.05; Cohen’s d =  0.51], 
Social Cognition [SZ  <  BD: t(76)  =  −3.13, p  <  0.05; Cohen’s 
d = 0.70], and the overall neurocognitive Composite [SZ < BD: 
t(76) = −2.81, p <  0.01; Cohen’s d =  0.64]. A series of partial 
correlations examining associations between clinical variables 
(YMRS, MADRS, PANSS Positive, PANSS Negative, PANSS 
General, and PANSS Total) and cognitive outcomes correcting 
for age and gender in the total patient sample and separately by 
diagnosis showed that clinical symptoms were not significantly 
associated with any neurocognitive domain, social cognition, or 
the composite score.
reward Processing
Probabilistic reward task data from several participants were 
excluded after quality control checks were performed blind to 
FigUre 2 | PrT response bias by group. PRT response bias scores by 
diagnosis across Block 1, Block 2, and Block 3, and response bias 
aggregated across Blocks 2 and 3 (RB Main).
FigUre 1 | MccB domain scores by group. MCCB domain (T scores) by 
diagnosis. Speed, Processing Speed; Attn, Attention; WM, Working Memory; 
Verbal, Verbal Learning and Memory; Visual, Visual Learning and Memory; 
ProbSolv, Problem Solving; Social, Social Cognition; Composite, Cognitive 
Composite.
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group assignment (below-chance responding, poor rich reward 
count, and too many outliers; SZ: n = 6; BD: n = 4; HC: n = 0). PRT 
scores did not differ by test version across the total sample or by 
diagnosis. Results indicated that when examined separately across 
the three blocks of the task, in the latter portion of the task only 
(RB main = mean RB in blocks 2 and 3) or across the entire task 
(RB total), PRT response bias did not differ significantly between 
patients and controls, or by diagnosis (all ps > 0.05; Table 2). Partial 
correlations conducted separately and by group accounting for the 
effects of age and gender showed no effect of these variables on 
response bias. Although not statistically significant, the BD group 
appeared to acquire a response bias more slowly than the HC or 
SZ groups (Figure 2). A main effect of Group emerged for PRT 
discriminability, a measure of overall task difficulty; specifically, 
patients with SZ and BD exhibited lower discriminability scores 
than the HC group [t(63) = 3.39; p < 0.01 and t(69) = 4.86; p < 0.001, 
respectively]; patients did not differ from each other [t(76) = 0.32, 
p = 0.75]. Results involving response bias did not change after con-
trolling for overall discriminability scores. As noted above, current 
substance abuse and history of substance dependence within the 
past year were exclusion criteria; however, data on lifetime history 
of substance abuse or dependence and lifetime and current tobacco 
and cannabis use patterns were available in a subset of patients. 
Thus, in order to examine the potential effects of smoking and 
other substance use on PRT response, we examined the effects 
of lifetime history of substance abuse (n = 44), lifetime history of 
tobacco smoking (n = 59) and current smoking status (n = 48), and 
lifetime and current cannabis use (n = 39) using partial correlation. 
After controlling for age and sex, none of our measures of smoking 
or other substance use was correlated with PRT response bias.
relationship between reward Processing 
and cognition
Correlations among PRT and MCCB variables showed that 
neither Social Cognition nor any of the neurocognitive domains 
was correlated with PRT response bias. Across groups, PRT 
discriminability was significantly correlated with most neu-
rocognitive domains, including Processing Speed (r  =  0.34, 
p <  0.001), Attention (r =  0.44, p <  0.001), Working Memory 
(r = 0.20, p < 0.05), Verbal (r = 0.40, p < 0.001), Visual (r = 0.35, 
p < 0.001), and the Cognitive Composite (r = 0.43, p < 0.001). In 
order to correct for multiple correlational analyses, we utilized 
a procedure adjusting for multiple correlations following the 
recommendations in Sankoh et al. (45). In this method, within 
groupings of correlational analyses p-values are adjusted by 
accounting for the number of correlations and the mean cor-
relation among all variables excluding the kth correlation. All 
significant correlations survived adjustment except Working 
Memory. Linear regression predicting MCCB measures by PRT 
response bias after accounting for the effects of sex, education, 
PRT discriminability, and diagnosis revealed that response bias 
was a significant predictor of Social Cognition (β  =  −10.78; 
t = −2.13, p < 0.05), such that lower response bias was associated 
with higher Social Cognition scores. The model did not predict 
any MCCB neurocognitive domain scores.
relationship between reward Processing 
and clinical symptom severity
PRT response bias was significantly correlated with several 
clinical scales, including PANSS Positive (r = −0.28, p < 0.05), 
PANSS Negative (r = −0.30 p < 0.05), PANSS General (r = −0.36, 
p < 0.01), and PANSS Total (r = −0.30, p < 0.05), with higher 
response bias being associated with less severe symptomatology. 
Partial correlations confirmed that these correlations remained 
significant when controlling for age and sex (all ps < 0.05). Note 
that using the above multiple comparisons correction only the 
correlation between PANSS General and PRT response bias 
remained significant [p(corr) < 0.05]; PANSS Negative and PANSS 
Total scores showed trend-level significance [p(corr)  =  0.05]. 
PRT response bias was not correlated with CPZ, mania severity, 
depression severity, state anxiety, or community functioning. 
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Partial correlations run separately by diagnosis showed that in 
the BD group, higher PRT response bias was associated with 
lower PANSS General scores after accounting for the effects of 
age and sex (r = −0.36; p = 0.05). There were no other significant 
associations between clinical symptoms and PRT scores, likely 
due to small sample size; however, the magnitude of the cor-
relations was similar to the total group, and comparable in the 
SZ and BD groups for most measures (PANSS Total: r = −0.29, 
r  =  −0.28; PANSS Negative: r  =  −0.28; r  =  −0.30; PANSS 
General: r = −0.33, r = −0.36, respectively). PANSS Positive and 
PRT response bias showed different associations by diagnosis 
(SZ: r = −0.33; BD: r = −0.09). The range of PANSS scores was 
comparable by group (SZ: 7–26; BD: 7–20). PRT discriminability 
was not correlated with any clinical measure or CPZ equivalents. 
When negative symptoms and positive symptoms were included 
in a regression model in separate steps, inclusion of positive 
symptoms after accounting for negative symptoms did not con-
tribute significantly to the prediction of PRT response bias; the 
reverse was also true.
Two sets of regression models were used to determine whether 
PRT response bias and cognitive functioning were predictors of 
positive and negative symptom severity in the patient groups after 
accounting for age, education, PRT discriminability, and social or 
neurocognitive score. For the first regression model, age, educa-
tion, PRT discriminability, PRT response bias, and the Cognitive 
Composite were entered as predictors; Social Cognition replaced 
the Composite in the second model. Response bias was a signifi-
cant predictor of PANSS Positive (β = −9.96, p < 0.05), PANSS 
Negative (β = −6.86, p <  0.05), PANSS General (β = −16.55, 
p < 0.01), and PANSS Total (β = −27.63, p < 0.05); neither the 
Cognitive Composite nor Social Cognition were significant 
predictors in any model.
DiscUssiOn
In the present study, we examined neurocognition, social cogni-
tion, and reward learning in patients with SZ, BD-I with psycho-
sis, and HC, and the association between cognitive functioning, 
reward learning, and clinical symptoms. As we hypothesized and 
consistent with previous findings, patients with BD and SZ exhib-
ited significant deficits in multiple domains of neurocognition 
compared to HC, with patients with BD performing between the 
level of HC and patients with SZ on most measures. Conversely, 
patients with BD did not differ from HC on the MSCEIT Social 
Cognition measure, and both patients with BD and HC per-
formed significantly better than patients with SZ. This suggests 
that, although neurocognitive functioning is impaired across 
the psychosis spectrum, some aspects of social cognition may be 
intact in patients with BD and may differentiate patients with BD 
from patients with SZ spectrum disorders. These findings support 
a growing literature demonstrating that deficits in the aspects 
of social cognition measured by the MSCEIT may represent a 
unique phenotype of SZ but not psychotic mood disorders (10, 
46). While many major symptom domains, such as neurocogni-
tion are now well known to cut across the “Kraepelinian divide,” 
some details of these symptoms and their expression may differ by 
diagnosis or illness dimension in meaningful ways. For instance, 
even within the domain of neurocognition in psychosis, evidence 
of distinct premorbid and prodromal trajectories by diagnosis 
(7) may reflect subtle but meaningful variation in etiological 
pathways, course mediators, or treatment indications.
Contrary to our hypothesis, neither patient group differed 
from HC on response bias in the PRT reward learning paradigm. 
Although some aspects of reward learning appear to be impaired 
in patients with psychosis, in our sample patients did not dif-
fer from healthy controls, suggesting that patients were able to 
successfully modify behavior as a function of reinforcement. 
This is consistent with recent findings from Hager and col-
leagues (47), who reported no difference between patients with 
SZ and healthy controls in neural activation in the context of a 
differentially rewarded n-back task, indicating that patients were 
able to successfully use reward processing to maximize cognitive 
performance.
Across groups, PRT response bias was not significantly cor-
related with any neurocognitive domain, but was associated with 
Social Cognition. This finding suggests that reward learning 
may be more closely tied with “hot” social cognitive processes as 
opposed to “cold” cognition. Interestingly, better reward learning 
on the PRT was actually associated with poorer social cognitive 
processing. One possible explanation for this unexpected finding 
is that the response choices in the MSCEIT task often include 
seemingly socially desirable but less nuanced selections. Reponses 
are given on a Likert scale, such that repeated selection of socially 
desirable choices may lead to an overall lower score, confounding 
the reinforcing effects of socially desirable decision-making with 
social cognitive processing and perspective taking. However, 
this finding needs further exploration. A post hoc correlational 
analysis revealed that Social Cognition was not correlated with 
any neurocognitive domain except Problem Solving (r =  0.20, 
p  <  0.05) and that neurocognitive domains showed a strong 
pattern of inter-correlation, with most domains modestly to 
moderately correlated with most or all other domains. This find-
ing suggests that social cognition as measured by the MSCEIT 
taps a unique domain of brain function, which does not overlap 
significantly with most other aspects of neurocognition but may 
share some common pathways with reward learning.
The present findings linking reward processing and social cog-
nition but not neurocognition suggest dissociable mechanisms 
of effect for these hallmark symptom dimensions. While social 
cognition is often considered a subdomain of neurocognition, 
it may rely on at least partially separable pathways that are dif-
ferentially associated with aspects of reward processing. Recent 
reports suggest potential common pathways between reward 
processing and social cognition both regionally and at the circuit 
level. Aspects of both social cognition (e.g., ToM) and reward 
and motivation are associated with brain regions, including 
anterior cingulate, amygdala, and areas of the prefrontal cortex. 
Also, connections between regions of the dorsolateral and ventral 
medial prefrontal cortex and anterior cingulate are implicated in 
both reward-based learning and aspects of social cognition (48). 
Patients with SZ show decreased BOLD activation and reduced 
gray matter volume in medial frontal and cingulate regions dur-
ing both reward learning (49) and social reasoning and ToM tasks 
(50). A recent study found that medial PFC activation during a 
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ToM task mediated the relationship between social AD and social 
functioning in patients with SZ (51), suggesting a possible shared 
neural pathway between ToM, AD, and social functional out-
comes in SZ. Collectively, these findings highlight associations 
between medial PFC and ACC activation and the relationship 
of these connections to reward learning, motivation, and AD, 
suggesting a neurobiological pathway linking these constructs, 
which may be abnormal in patients with SZ and related disorders.
In terms of clinical symptoms, response bias was associated 
with psychotic symptom severity across patient groups, including 
positive symptoms, negative symptoms, and general symptoms, 
although after multiple comparisons correction only the associa-
tion with general symptoms remained significant, with negative 
and total scores at the trend level. State mood and anxiety 
symptoms were not associated with reward learning measures. 
Substantial literature supports the association between negative 
symptoms and aspects of reward and motivation; our findings 
indicate that reward learning was associated negative symptoms 
and general symptoms of psychosis across diagnoses, suggesting 
that these associations reflect dimensions that cut across diagnos-
tic boundaries. However, response bias was only associated with 
positive symptoms in patients with SZ; this differential pattern of 
associations suggests that the relationship of response bias with 
positive symptoms of psychosis may differ by diagnosis, perhaps 
based on differences in the nature of positive symptoms in these 
patient groups. While outside the scope of this work, careful 
evaluation of positive symptom items or factors that predict 
response bias would help clarify these relationships.
The present study has several limitations; most notably, only 
one measure of reward processing (a behavioral measure of 
reward learning) was included, limiting our ability to examine 
multiple aspects of reward processing and their differential 
associations with neuro- and social cognitive performance and 
clinical symptoms. Studies using multiple measures of reward 
processing tapping putatively different domains will help clarify 
the relationships among specific aspects of these key symptom 
domains. Additionally, two slightly different PRT versions were 
used in this study. However, PRT version was not associated 
with response bias in our sample. Across studies, subjects were 
excluded if they endorsed current substance abuse or recent 
dependence; we are, therefore, unable to examine associations 
between current substance misuse and reward and cognition. 
However, lifetime history of abuse or dependence was not 
associated with PRT response bias. In terms of smoking, data 
regarding history of smoking were available for only a subset 
of our participants; however, in this subset history of smoking 
was not associated with response bias. Information on medical 
comorbidity was not collected. Per our exclusion criteria, patients 
with histories of head trauma, seizure disorder, or other major 
neurological/medical illnesses that may suggest a non-idiopathic 
psychosis were not eligible to participate. Our sample was young, 
with a mean age of approximately 32 years, suggesting low risk for 
major medical burden that might significantly impact cognitive 
status. However, we cannot rule out the possibility that medi-
cal conditions affected participants’ cognitive status. Lastly, our 
participants were largely stable outpatients at the time of test-
ing, limiting our ability to generalize findings to patients with 
more acute exacerbations, or to stratify our samples based on 
SZ subtypes or current polarity in our BD sample. The relation-
ships among cognition, symptoms, and reward during stability/
euthymia versus exacerbation and the extent to which associa-
tions converge or decouple with symptom fluctuation should be 
a focus of future work.
In sum, reward learning was associated with symptoms of 
psychosis – in particular negative symptoms – across diagnoses, 
and was predictive of scores on the MSCEIT Social Cognition 
task. Reward learning was not associated with neurocognitive 
performance, however, suggesting that social cognition but not 
neurocognition may share common pathways with this aspect 
of reinforcement learning. Better understanding of the associa-
tions among reward and cognition will clarify the pathways that 
are shared and distinct in these key symptom dimensions, and 
may hasten the development of interventions to target these 
domains.
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